{
    "1721112622634791303": {
        "author_id": "62465691",
        "created_at": "2023-11-05T10:30:00.000Z",
        "edit_history_tweet_ids": [
            "1721112622634791303"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 118,
                    "normalized_text": "CKD",
                    "probability": 0.4576,
                    "start": 116,
                    "type": "Other"
                },
                {
                    "end": 150,
                    "normalized_text": "RAASi",
                    "probability": 0.5716,
                    "start": 146,
                    "type": "Other"
                },
                {
                    "end": 169,
                    "normalized_text": "HK",
                    "probability": 0.4091,
                    "start": 168,
                    "type": "Place"
                }
            ]
        },
        "id": "1721112622634791303",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 5136,
            "like_count": 6,
            "quote_count": 0,
            "reply_count": 5,
            "retweet_count": 2
        },
        "text": "A new dual-country real-world evidence study found that risk of progression to kidney failure is over 70% higher in CKD patients who discontinued RAASi therapy after a HK event compared to patients who remained on this lifesaving therapy."
    }
}